Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Decentralized procedure for European approval of pitavastatin reaches positive conclusion

July 16, 2010

Merck & Co. claims new GPR119 receptor agonists

July 16, 2010

Hologic resubmits Gestiva NDA for prevention of preterm birth

July 15, 2010

LCT reports additional phase II data on DiabeCell in type 1 diabetes

July 15, 2010

ONO-5334 has beneficial effects on bone in postmenopausal women

July 15, 2010

Betagenon claims new AMPK activators

July 15, 2010

Lorcaserin reduces body weight in phase III BLOOM/BLOSSOM trials

July 15, 2010

DegludecPlus effective in type 2 diabetes in proof-of-concept trial

July 14, 2010

Phase III data reveal effects of add-on dapagliflozin in poorly controlled diabetes

July 14, 2010

Merck & Co. characterizes new histamine H3 receptor ligands

July 14, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...